Susquehanna International Securities’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-40,000
Closed -$1.9M 83
2020
Q1
$1.9M Buy
40,000
+9,200
+30% +$491K 0.77% 30
2019
Q4
$1.81M Sell
30,800
-300,800
-91% -$16.7M 0.69% 39
2019
Q3
$17.7M Buy
331,600
+290,800
+713% +$15M 3.87% 7
2019
Q2
$2.04M Sell
40,800
-195,280
-83% -$9.8M 0.66% 39
2019
Q1
$12.3M Buy
+236,080
New +$11.8M 3.03% 11

Other funds holding GSK

Susquehanna International Securities's GSK Position: Q1 2024 in Review

Susquehanna International Securities sold out of GSK (GSK) in Q1 2024, closing a stake of 20,308 shares — an estimated $753K sold.

Susquehanna International Securities first reported a position in GSK in Q4 2019 and held it in 3 quarters. The position peaked at $3.95M in Q4 2019. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Susquehanna International Securities reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Securities sold 20,308 GSK shares in Q1 2024, an estimated $753K.
  • Susquehanna International Securities first reported a position in GSK in Q4 2019 and held it in 3 quarters.
  • Susquehanna International Securities's GSK position peaked at $3.95M in Q4 2019.
  • 911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Susquehanna International Securities's 13F filing for Q1 2024, filed 7 May 2024.